Constellation Brands' Stock Slips 1% on Q1 Earnings & Sales Miss

Constellation Brands (STZ) reported a Q1 fiscal 2026 earnings and sales miss, with comparable EPS of $3.22 and net sales of $2.52 billion falling below consensus estimates, leading to a 1.2% stock decline in after-market trading. The underperformance was primarily driven by weak consumer demand, resulting in a 2% decline in beer sales due to lower Modelo and Corona volumes, and a significant 28% plunge in wine and spirits revenue, partly attributed to the SVEDKA divestiture. Despite generating strong cash flow, STZ reiterated a cautious FY26 outlook, projecting enterprise organic net sales between a 2% decline and 1% increase, with continued sharp declines anticipated for the wine and spirits segment.

Analysis

Constellation Brands reported a weak first quarter for fiscal 2026, missing consensus estimates on both revenue and earnings, which triggered a 1.2% after-market stock decline. Net sales fell 5.5% to $2.52 billion and comparable EPS dropped 10% to $3.22, primarily attributed to soft consumer demand. The core beer segment, typically a growth engine, saw sales fall 2% as shipment volumes declined 3.3%, with notable weakness in its flagship Modelo and Corona brands, which saw depletion volumes dip 4% and over 7%, respectively; the double-digit growth in Pacifico was insufficient to offset this. The Wine and Spirits segment experienced a severe contraction, with sales plunging 28% and the division swinging to a $6 million operating loss from a $59.7 million profit a year ago, exacerbated by the SVEDKA divestiture and weak mainstream demand. Margin pressure was evident across the business, with the beer segment's operating margin contracting 150 basis points to 39.1% due to higher costs. Despite these operational headwinds and a stock that has underperformed its industry by over 6% in the last three months, management reiterated its full-year guidance. However, this outlook implies a challenging year ahead, with a forecasted decline in comparable EPS to $12.60-$12.90 from $13.78 in fiscal 2025 and a steep 17-20% organic sales decline for the Wine and Spirits segment. The company's strong free cash flow of $444.4 million and capital return program, including a $381 million share repurchase, provide some support, but do not mask the negative near-term earnings trajectory.

Key Decisions for Investors

• Investors should closely monitor depletion volume trends for the core Modelo and Corona brands in coming quarters, as a recovery in these is critical to reversing the negative sentiment, given Pacifico's growth is not currently sufficient to offset their decline.
• The severe underperformance and operating loss in the Wine and Spirits segment warrant caution; consider this division a significant drag on overall results and watch for further divestitures or strategic shifts.
• Given the guidance for a year-over-year decline in comparable EPS for fiscal 2026, re-evaluate valuation metrics as the company's earnings growth has reversed, despite its consistent cash flow and shareholder returns.
• Consider the relative underperformance and fundamental weakness against peers like Coca-Cola, which the report notes has a positive growth outlook, suggesting a potential rotation for those seeking more stable consumer demand exposure.